Predictive Oncology Inc. Enters Securities Purchase AgreementPittsburgh, Pennsylvania – Predictive Oncology Inc. (NASDAQ: POAI) disclosed on February 18, 2025, that it has ventured into a Securities Purchase Agreement. This agreement involved the sal

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Predictive Oncology’s 8K filing here.

About Predictive Oncology

(Get Free Report)

Predictive Oncology Inc operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples.

Recommended Stories